NewsBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39223.749826.DB (Published 24 May 2007) Cite this as: BMJ 2007;334:1078
US drug maker fined for misleading public: The Connecticut based Purdue Frederick Company has pleaded guilty to misbranding the opiate analgesic OxyContin (oxycodone hydrochloride) with intent to defraud and mislead the public over its addictive qualities. The drug maker was fined $634.5m (£320m; €470m).
Watchdog calls for vitamin enriched bread: Bread should be fortified with folic acid to reduce birth defects such as spina …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial